Clinical Trials Logo

Filter by:
NCT ID: NCT01158235 Completed - Nasal Carriers MRSA Clinical Trials

A Phase I/IIa Study to Evaluate the Safety, Tolerability and Efficacy of Topical LTX-109 in Subjects Nasally Colonized With Methicillin-resistant/-Sensitive Staphylococcus Aureus (MRSA/MSSA)

Start date: May 2010
Phase: Phase 1/Phase 2
Study type: Interventional

This is a pilot study conducted to evaluate the safety, local tolerability and efficacy of LTX-109(Lytixarâ„¢), a lytic peptide designed to kill bacterias quickly and efficient. LTX-109 (Lytixarâ„¢)will be applied in the anterior nares in subjects who are carriers of nasal colonies of MRSA/MSSA. The extent of systemic absorption of LTX -109 when applied to the anterior nares will be evaluated and the effect of Lytixarâ„¢ as to clear colonies of MRSA/MSSA during the the observation period and Week 2 to Week 9 after treatment.

NCT ID: NCT01156246 Completed - Healthy Clinical Trials

Study to Assess the Effect of Food on Combination Dapagliflozin/Metformin Tablet in Healthy Volunteers

Start date: June 2010
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine whether treatment with a fixed dose combination dapagliflozin/metformin tablet is affected by food.

NCT ID: NCT01153607 Completed - Diagnostic Imaging Clinical Trials

Evaluation of the Diagnostic Potential of BAY1006578 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of BAY1006578 in Healthy Volunteers

Start date: June 2010
Phase: Phase 1
Study type: Interventional

PET (positron emission tomography) imaging with BAY1006578 for investigation of diagnostic potential in probable Alzheimer Disease patients versus healthy volunteers and radiation dosimetry in healthy volunteers.

NCT ID: NCT01152749 Completed - Tobacco Dependence Clinical Trials

Bioequivalence Between an Oral Nicotine Replacement Product and Nicorette® Gum

Start date: December 2009
Phase: N/A
Study type: Interventional

This study examines the bioequivalence between an oral nicotine replacement product and Nicorette® gum.

NCT ID: NCT01152736 Completed - Tobacco Dependence Clinical Trials

Pharmacokinetics With a New Oral Nicotine Replacement Product and Nicorette® Gum

Start date: November 2008
Phase: N/A
Study type: Interventional

Single-dose pharmacokinetics with a new oral nicotine replacement product and Nicorette® gum.

NCT ID: NCT01152723 Completed - Tobacco Dependence Clinical Trials

Pharmacokinetics With Two New Oral Nicotine Replacement Products and Nicorette® Gum

Start date: March 2008
Phase: N/A
Study type: Interventional

Single-dose pharmacokinetics with two new oral nicotine replacement products and Nicorette® gum.

NCT ID: NCT01152606 Completed - Breast Cancer Clinical Trials

A Study of Cardiac Safety in Patients With HER2 Positive Early Breast Cancer Treated With Herceptin

Start date: August 30, 2007
Phase: N/A
Study type: Observational

This is a single cohort observational safety study. All patients will be treated and monitored according to the local clinical practice. No additional procedures/patient visits in comparison with the usual clinical practice are planned for the study. Data will be collected from centre's medical records for up to 5 years or death.

NCT ID: NCT01152567 Completed - Hypertension Clinical Trials

Effects of Angiotensin Converting Enzyme (ACE) Inhibitors Versus Candesartan in Reducing Cardiovascular Events in Primary Treatment of Hypertension

ARBACE
Start date: June 2010
Phase: N/A
Study type: Observational

The planned Study will be a retrospective study on the effect of ACE's vs. candesartan on cardiovascular events and on health economic effects in a "real life" setting in Sweden.

NCT ID: NCT01152047 Completed - Dyspepsia Clinical Trials

The Effect of Oxytocin on Gastric Emptying

Start date: May 2010
Phase: N/A
Study type: Interventional

The investigators have seen that oxytocin lowers satiety in healthy subjects. Patients with dyspepsia suffers from decreased accommodation and increased satiety postprandially. The investigators now want to examine whether oxytocin may diminish symptoms in these patients.

NCT ID: NCT01151020 Completed - Aortic Aneurysm Clinical Trials

TX2® Low Profile TAA Endovascular Graft

TX2® LP
Start date: March 2010
Phase: N/A
Study type: Interventional

The Zenith® TX2® Low Profile TAA Endovascular Graft study is a clinical trial approved by US FDA to evaluate the safety and effectiveness of the Zenith® TX2® Low Profile TAA Endovascular Graft indicated for the treatment of patients with aneurysms/ulcers of the descending thoracic aorta having vessel structure suitable for repair.